Inside the Execution Chamber: The Questions That Tennessee Must Answer

Inside the Execution Chamber: The Questions That Tennessee Must Answer
September 30, 2026, was supposed to be the final day of Christa Pike’s life.
The Tennessee Department of Correction prepared to carry out her sentence at Riverbend Maximum Security Institution.
Pike had been convicted of the 1995 murder of Colleen Slemmer.
After years of appeals and legal proceedings, the execution was allowed to proceed.
But the procedure quickly became a medical controversy.
Pike received pentobarbital, the drug used in Tennessee’s lethal injection protocol.
Yet she did not die.
Witnesses reportedly observed signs that she was still breathing and making sounds.
Her attorneys raised concerns as the situation continued.
A second dose was administered under the state’s protocol.
Even then, Pike survived.
The execution was ultimately halted, and emergency medical treatment became necessary.
She was transported to hospital for intensive care.
Questions immediately emerged about the intravenous lines and the delivery of the drugs.
Some medical experts suggested that problems with the IV access could have played a role.
However, the precise cause remained unresolved.
Tennessee officials faced growing pressure to explain what had happened.
The incident transformed Pike’s case into a wider debate about the reliability and safety of execution procedures.
The most important question remained unanswered: How did an execution intended to end a life become a medical emergency that left the prisoner alive?